TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19002168

Br. J. Cancer 2008 Dec 2 99 11 1849-58

Download in:

View as

General Info

PMID
19002168